Adrenal disease

Contemporary global management of 21-hydroxylase deficiency congenital adrenal hyperplasia in early infancy: a multi-national registry study

Eur J EndocrinolPublished Retrospective registry study

Authors' conclusion

Contemporary management of CAH in early infancy varies considerably. Hypertension and hyperkalemia are frequently reported. Our data may help inform development of quality indicators for benchmarking CAH care in infancy.

Study context

Population
Infants with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH) born in 2018–2023, I-CAH Registry, 33 centers in 18 countries; management over the first 90 days of life92 female, 62 male
Participants
154 infants
Outcome
Management of CAH in early infancy
Follow-up
First 90 days of life
Methodological detailsmultinational, multicentre
  • Multinational
  • Multicentre

Main finding

As reported in the abstract

Diagnosed postnatally
136
Presentation age, median (10th, 90th centile)
Day 4 (0, 20.8)
Hydrocortisone (HC) dose at initial hospital discharge, median (10th, 90th centile)
17 (11.4, 39.6) mg/m²/day
Fludrocortisone (FC) dose at initial hospital discharge, median (10th, 90th centile)
100 (50, 200) mcg/day
Salt dose at initial hospital discharge, median (10th, 90th centile)
3.5 (1.6, 8.7) mmol/kg/day
HC dose at D90, median (10th, 90th centile)
14.5 (8.7, 24.1) mg/m²/day
FC dose at D90, median (10th, 90th centile)
100 (50, 200) mcg/day
Salt dose at D90, median (10th, 90th centile)
2.1 (1.0, 5.2) mmol/kg/day
Total hospitalization duration over 90 days, median (10th, 90th centile)
9 days (2, 24)
Seen by a pediatric endocrinologist by D90 (males:females)
95.9% (58:84)
Seen by a psychologist by D90 (males:females)
33.3% (9:35)
Seen by a pediatric endocrine nurse specialist by D90 (males:females)
42.1% (20:36)
Seen by a surgeon by D90 (males:females)
23.8% (0:35)

Observational data: associations, not effects.

Further findings

BP measurement at D90

BP measurements recorded
30.5%
Hypertension reported among those with BP recorded
31.9%

Safety

Electrolyte disturbances, hypoglycemia and adrenal crises · first 90 days of life

Hyponatremia
70.0%
Hyperkalemia
71.9%
Hypoglycemia
13.0%
Hyponatremia at D90
7.4%
Hyperkalemia at D90
28.6%
Hospitalization episodes associated with adrenal crises
40. 6%

Original publication

Contemporary global management of 21-hydroxylase deficiency congenital adrenal hyperplasia in early infancy: a multi-national registry study. Eur J Endocrinol. Published 14 January 2026. doi:10.1093/ejendo/lvag004

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.